Donanemab : on fait le point episode artwork

EPISODE · Dec 23, 2025 · 8 MIN

Donanemab : on fait le point

from Focus

Focus sur le Donanemab (Kisunla), récemment approuvé par l'Agence européenne des médicaments. 📅 Après un refus en mars 2025, ce traitement novateur a finalement reçu le feu vert européen le 25 septembre dernier. Mais que change-t-il concrètement pour les patients et surtout : qu'en est-il des prochaines étapes en France ?

Episode metadata supplied by the publisher feed · Published Dec 23, 2025

Embed this episode

Ready to play

Donanemab : on fait le point

0:00 8:20

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Focus?

This episode is 8 minutes long.

When was this Focus episode published?

This episode was published on December 23, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Focus episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!